Literature DB >> 30310693

Abstracts from the European Respiratory Society Annual Conference 2018 on Thoracic Oncology.

Clementine Bostantzoglou1, Marianthi Iliopoulou2, Torsten Gerriet Blum3.   

Abstract

Year:  2018        PMID: 30310693      PMCID: PMC6174125          DOI: 10.21037/jtd.2018.08.121

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.

Authors:  Rianne de Vries; Yennece W F Dagelet; Pien Spoor; Erik Snoey; Patrick M C Jak; Paul Brinkman; Erica Dijkers; Simon K Bootsma; Fred Elskamp; Frans H C de Jongh; Eric G Haarman; Johannes C C M In 't Veen; Anke-Hilse Maitland-van der Zee; Peter J Sterk
Journal:  Eur Respir J       Date:  2018-01-11       Impact factor: 16.671

2.  Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial.

Authors:  J Hetzel; R Eberhardt; F J F Herth; C Petermann; G Reichle; L Freitag; I Dobbertin; K J Franke; F Stanzel; T Beyer; P Möller; P Fritz; G Ott; P A Schnabel; H Kastendieck; W Lang; A T Morresi-Hauf; M N Szyrach; R Muche; P L Shah; A Babiak; M Hetzel
Journal:  Eur Respir J       Date:  2011-08-18       Impact factor: 16.671

Review 3.  EGFR mutations and lung cancer.

Authors:  Gilda da Cunha Santos; Frances A Shepherd; Ming Sound Tsao
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 4.  Understanding the Links Between Lung Cancer, COPD, and Emphysema: A Key to More Effective Treatment and Screening.

Authors:  Luis M Seijo; Javier J Zulueta
Journal:  Oncology (Williston Park)       Date:  2017-02-15       Impact factor: 2.990

5.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

6.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

7.  Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Authors:  Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Michael V Di Maria; Robert Veve; Roy M Bremmes; Anna E Barón; Chan Zeng; Wilbur A Franklin
Journal:  J Clin Oncol       Date:  2003-09-02       Impact factor: 44.544

8.  Flow cytometric analysis of CD133- and EpCAM-positive cells in the peripheral blood of patients with lung cancer.

Authors:  Tomasz Skirecki; Grażyna Hoser; Jerzy Kawiak; Dariusz Dziedzic; Joanna Domagała-Kulawik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02       Impact factor: 4.291

9.  Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: a retrospective case series.

Authors:  Sergej Griff; Nicolas Schönfeld; Wilhelm Ammenwerth; Torsten-Gerriet Blum; Christian Grah; Torsten T Bauer; Wolfram Grüning; Thomas Mairinger; Henrik Wurps
Journal:  BMC Pulm Med       Date:  2014-11-03       Impact factor: 3.317

10.  A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.

Authors:  K E Ware; T K Hinz; E Kleczko; K R Singleton; L A Marek; B A Helfrich; C T Cummings; D K Graham; D Astling; A-C Tan; L E Heasley
Journal:  Oncogenesis       Date:  2013-03-25       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.